Newsletter | May 19, 2025

05.19.25 -- DEI Was Never the Problem, The Way Pharma Did It Was

PATIENT CENTRICITY

Listen Up, Pharma: C. diff Patient Advocate Shares Tips To Better Understand Patients

Guest Column | A conversation with Christian John Lillis, The Peggy Lillis Foundation

The Peggy Lillis Foundation CEO Christian John Lillis discusses his experience advocating for C. diff therapies, highlighting successes as well as shortcomings in feeling heard.

Understanding The Perceptions And Potential Of Clinical Research

e-book | PA Consulting

The PA Consulting Clinical Trials Pulse Report 2024 presents a compelling picture of public perceptions, challenges, and innovation opportunities in clinical trial design and delivery.

The Evolution Of Communication In Healthcare And Clinical Trials

Article | Jumo Health

Educational animation in clinical trials enhances patient understanding, health literacy, and retention, addressing diverse literacy needs by simplifying complex information into engaging visual content.

Five Predictions For Clinical Research In 2025

Article | By Mo Punjwani, Mural Health

In 2025, AI-powered adaptive protocols will redefine study design, shifting the industry from rigid, pre-planned models to flexible, real-world-optimized trials.

PATIENT RECRUITMENT

DEI Was Never the Problem, The Way Pharma Did It Was

Guest Column | By Denise Bronner, Ph.D., Empactful Ventures

Consultant Denise Bronner details pharma's strategic rollback of DEI initiatives, roles, and even departments and explains why well-meaning but misguided intentions enabled their demise.

We Can Fix What's Broken in Research—If We Solve the Right Problems

Article | Scout

Addressing the root causes of inefficiencies in research is the only way to drive meaningful progress. Explore why tackling the right issues is essential to fixing broken research process.

Importance Of Patient Recruitment In Clinical Trials

Q&A | Novotech

Explore this comprehensive overview of patient recruitment in clinical trials, emphasizing its critical role in ensuring diverse and representative participant pools essential for credible research outcomes.

Assessment Revolutionizes CNS Trial Outcomes: CDR Attention Battery

Article | By Helen Brooker and Pascal Goetghebeur, Signant Health

Discover how this validated 7-minute cognitive assessment transforms CNS trials through precise patient stratification, objective attention measurements, and enhanced signal detection.

Consent By Proxy: The Key To More Inclusive, More Reliable Trials

Article | By Cal Collins, OpenClinica

Explore innovative digital workflow designed specifically for Legally Authorized Representative (LAR) to help overcome the challenges of complex documentation and data management issues.

Reducing The Travel Burden For Patients - Mobile Vision Clinics

Video | 20/20 Onsite

Travel to trial sites can be a major hurdle for patients considering participation, but mobile vision clinics are providing a solution to improve accessibility, capacity, and patient enrollment.

CLINICAL SITES

How Sites Are Often Evaluated By Sponsors

Embedded Video | By Clinical Leader Live

Adam Kinsey described how sponsor-site partnerships at Merck typically start small. Sites are evaluated not only on enrollment but on predictability and communication throughout a study.

6 AI And Machine Learning Considerations For Trial Management

Infographic | Thermo Fisher Scientific

Are you considering integrating AI and ML into your workflow? These six considerations will help you plan out an effective trial.

Cutting-Edge Tech Improving Global Participant Payment Paradigms

Article | By Shaun Williams, IQVIA Technologies

Participant payment management is essential for successful global clinical trials, as it enables diverse regulatory compliance, enhances participant satisfaction, and streamlines execution.

Community-Focused Site Networks Transforming Clinical Trials

Article | By Kerry Leyden, MRN - Medical Research Network

Leveraging a site network has proven to ease study enrollment, contracting, and budgeting, while also reducing overall study cost and timelines.

How Do Site Payments Impact Clinical Trial Sustainability?

Article | By Michelle Ray, Greenphire

Financial stability is critical for trial sites, yet many sites grapple with substantial payment delays. To mitigate these challenges, it's imperative to reassess traditional payment practices,

CHOOSE YOUR OWN ADVENTURE

You're receiving the Monday edition of the Clinical Leader newsletter, focusing on Clinical Sites, Patient Centricity, and Patient Recruitment. To make changes to your newsletter selections, update your topic preferences.

  • Clinical Sites | Patient Centricity | Patient Recruitment (Monday)
  • Clinical Trial Technology (Tuesday)
  • Decentralized Trials | Trial Management (Wednesday)
  • Outsourcing Models | Regulatory & Compliance (Thursday)
  • Clinical Data Management & Analytics | Trial Monitoring (Friday)

Learn more about our personalized newsletters here.

Connect With Clinical Leader: